Literature DB >> 6025485

Studies on the intracerebral toxicity of ammonia.

S Schenker, D W McCandless, E Brophy, M S Lewis.   

Abstract

Interference with cerebral energy metabolism due to excess ammonia has been postulated as a cause of hepatic encephalopathy. Furthermore, consideration of the neurologic basis of such features of hepatic encephalopathy as asterixis, decerebrate rigidity, hyperpnea, and coma suggests a malfunction of structures in the base of the brain and their cortical connections. The three major sources of intracerebral energy, adenosine triphosphate (ATP), phosphocreatine, and glucose, as well as glycogen, were assayed in brain cortex and base of rats given ammonium acetate with resultant drowsiness at 5 minutes and subsequent coma lasting at least 30 minutes. Cortical ATP and phosphocreatine remained unaltered during induction of coma. By contrast, basilar ATP, initially 1.28 +/- 0.15 mumoles per g, was unchanged at 2.5 minutes but fell by 28.1, 27.3, and 26.6% (p < 0.001) at 5, 15, and 30 minutes after NH(4)Ac. At comparable times, basilar phosphocreatine fell more strikingly by 62.2, 96, 77.1, and 71.6% (p < 0.001) from a control level of 1.02 +/- 0.38 mumoles per g. These basilar changes could not be induced by anesthesia, psychomotor stimulation, or moderate hypoxia and were not due to increased accumulation of ammonia in the base. Glucose and glycogen concentrations in both cortex and base fell significantly but comparably during development of stupor, and prevention of the cerebral glucose decline by pretreatment with glucose did not obviate ammonia-induced coma or the basilar ATP fall. These findings represent the first direct evidence that toxic doses of ammonia in vivo acutely affect cerebral energy metabolism and that this effect is preferentially localized to the base of the brain.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025485      PMCID: PMC297085          DOI: 10.1172/JCI105583

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  VARIATION OF CEREBRAL CORTEX FLUID SPACES IN VIVO AS A FUNCTION OF SPECIES BRAIN SIZE.

Authors:  R S BOURKE; E S GREENBERG; D B TOWER
Journal:  Am J Physiol       Date:  1965-04

2.  The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma.

Authors:  S P BESSMAN; A N BESSMAN
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

3.  Mechanism of inhibitory action of ammonia on the respiration of rat-liver mitochondria.

Authors:  A WORCEL; M ERECINSKA
Journal:  Biochim Biophys Acta       Date:  1962-11-19

4.  Hepatic coma: clinical considerations, pathogenesis, and management.

Authors:  G J GABUZDA
Journal:  Adv Intern Med       Date:  1962

5.  A colorimetric method for the measurement of the brain ammonia of the mouse; the effect of glutamine on the total measurable ammonia.

Authors:  D G NATHAN; K S WARREN
Journal:  Arch Biochem Biophys       Date:  1959-04       Impact factor: 4.013

6.  The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy.

Authors:  J B POSNER; F PLUM
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

7.  Some factors influencing cerebral oxidation in relation to hepatic coma.

Authors:  J M WALSHE; L DE CARLI; C S DAVIDSON
Journal:  Clin Sci       Date:  1958-02       Impact factor: 6.124

8.  Effect of temperature variation on toxicity and metabolism of ammonia in mice.

Authors:  S SCHENKER; K S WARREN
Journal:  J Lab Clin Med       Date:  1962-08

Review 9.  Pathogenesis of hepatic coma.

Authors:  L Zieve
Journal:  Arch Intern Med       Date:  1966-09

10.  Water, electrolytes, and extracellular space in hydrated and dehydrated brains.

Authors:  A Van Harreveld; H Collewijn; S K Malhotra
Journal:  Am J Physiol       Date:  1966-02
View more
  31 in total

1.  The normal colonic bacterial flora.

Authors:  M J Hill; B S Drasar
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

Review 2.  Effects of hyperammonemia on brain protein kinase C substrates.

Authors:  E Grau; G Marcaida; C Montoliu; M D Miñana; S Grisolía; V Felipo
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

3.  Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication.

Authors:  E Kosenko; Y Kaminsky; O Lopata; N Muravyov; A Kaminsky; C Hermenegildo; V Felipo
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

4.  Effect of ammonia intoxication on cerebral blood flow, its autoregulation and responsiveness to carbon dioxide and papaverine.

Authors:  A Chodobski; J Szmydynger-Chodobska; K Skolasińska
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

5.  [Pathophysiological aspects of circulation and respiration in life-threatening infections (septic shock)].

Authors:  W Thimme; W Dissmann; H J Buschmann; J Daugs; R Eisele; B Ramdohr
Journal:  Klin Wochenschr       Date:  1972-07-15

6.  Cerebral edema in the rat with galactosamine induced severe hepatitis.

Authors:  U B Gröflin; H Thölen
Journal:  Experientia       Date:  1978-11-15

7.  Prevention of ammonia toxicity by L-carnitine: metabolic changes in brain.

Authors:  J E O'Connor; M Costell; S Grisolía
Journal:  Neurochem Res       Date:  1984-04       Impact factor: 3.996

8.  Chemically responsive nanoporous pigments: colorimetric sensor arrays and the identification of aliphatic amines.

Authors:  Jin Ho Bang; Sung H Lim; Erwin Park; Kenneth S Suslick
Journal:  Langmuir       Date:  2008-10-25       Impact factor: 3.882

9.  Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine.

Authors:  W B Rowe; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

10.  Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts.

Authors:  B Hindfelt; F Plum; T E Duffy
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.